Post Marketing Observational Study of Retreatment of Chronic Hepatitis C With Peginterferon Alpha and Ribavirin (Study P06011)

Post Marketing Observational/Non-Interventional Study Of Retreatment Of Chronic Hepatitis C With Peginterferon Alpha And Ribavirin

To study retreatment in patients who failed prior treatment with interferon alpha (pegylated or non-pegylated) with or without ribavirin in a real-life setting in an observational/noninterventional study.

This is an observational/non interventional study to collect data on the patient characteristics of those seeking retreatment as well as safety and efficacy information during the first 12 weeks of retreatment.

Inclusion Criteria:

• Chronic hepatitis C of any genotype;
• Prior treatment with interferon alpha (pegylated or non-pegylated) with or without ribavirin did not result in a sustained virological response;
• Inclusion criteria listed on the approved label in each country;
• Willingness of the patient to participate and sign the Informed Consent Form.

Exclusion Criteria:

• Patient exclusion from this observational/non-interventional study will be determined by the treating physician and will be based on the local label in each country.